Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.12 | N/A |
PEG Ratio (TTM) | 0.00 | N/A |
P/S Ratio (TTM) | 1.78 | N/A |
P/B Ratio (TTM) | 0.20 | N/A |
P/FCF Ratio (TTM) | -0.61 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -105.22% | N/A |
ROE (TTM) | -408.79% | N/A |
Net Profit Margin (TTM) | -413.88% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -37.26% | -405.55% | N/A |
Revenue | -0.42% | 192.93% | N/A |
Net Income | 0.41% | -371.76% | N/A |
Cash Flow | 6.20% | -872.04% | N/A |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.52 | N/A |
Quick Ratio (TTM) | 3.33 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | -403.94 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |